metritason
Metritason is a synthetic glucocorticoid historically used in the treatment of a variety of conditions, including rheumatoid arthritis, asthma, and skin disorders. It was first synthesized in the early 1950s and was marketed as a potentially safer alternative to other glucocorticoids available at the time.
Due to its potency and systemic effects, metritason was primarily administered orally or intravenously. It exhibited
As research continued, potential toxic effects and interactions with other medications became clear. Despite initial enthusiasm,
Human studies have shown distinct pharmacokinetic profiles when metritason is taken orally versus intravenously. Peak blood
Though metritason was effective in the treatment of specific conditions, the availability of safer glucocorticoids developed